Negotiating innovative relationships with pharmaceutical companies: Integrated health systems’ perspective
نویسندگان
چکیده
منابع مشابه
Right-to-health responsibilities of pharmaceutical companies.
Unlike the health of our bodies, the health of our minds is often neglected. In 2007, The Lancet’s Series on Global Mental Health sought to draw attention to the worldwide burden of mental illness. Data published by Michael Phillips and colleagues in this issue indicate that mental health disorders might aff ect far more people than previously estimated. Their study took on the challeng ing tas...
متن کاملThe reasons behind medicine shortages from the perspective of pharmaceutical companies and pharmaceutical wholesalers in Finland
The aim of this study was to explore the reasons behind medicine shortages from the perspective of pharmaceutical companies and pharmaceutical wholesalers in Finland. The study took the form of semi-structured interviews. Forty-one pharmaceutical companies and pharmaceutical wholesalers were invited to participate in the study. The pharmaceutical companies were the member organizations of Pharm...
متن کاملInnovative devices for integrated circuits – A design perspective
MOS devices go 3D, new quantum effect devices appear in the research labs. This paper discusses the impact of various innovative device architectures on circuit design. Examples of circuits with FinFETs or Multi-Gate-FETs are shown and their performance is compared with classically scaled CMOS circuits both for digital and analog applications. As an example for novel quantum effect devices beyo...
متن کاملBuyouts of Indian Pharmaceutical Companies by Multinational Pharmaceutical Companies: An Issue of Concern
healthcare and Ranbaxy have been bought by Abbott and Daiichi Sankyo, respectively.[3] Cipla, an indigenous company, lone with a market share of about 5.4% tops the list of top 10 companies in India. The increasing presence of foreign companies among the top pharmaceutical companies in India is may be due to a few buyouts which happened in the recent past. Daiichi Sankyo, a leading Japanese pha...
متن کاملVirtual pharmaceutical companies: collaborating flexibly in pharmaceutical development.
Research and development (R&D) collaborations represent one approach chosen by the pharmaceutical industry to tackle current challenges posed by declining internal R&D success rates and fading of the blockbuster model. In recent years, a flexible concept to collaborate in R&D has emerged: virtual pharmaceutical companies (VPCs). These differ from other R&D companies, such as biotech start-ups, ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Health-System Pharmacy
سال: 1996
ISSN: 1079-2082,1535-2900
DOI: 10.1093/ajhp/53.4_suppl_1.s39